Source: Trial Site News

With ivermectin now on the national Indian COVID-19 list of recommended treatments for COVID-19, a few states have gone to the next level and included the low-cost, generic drug approved throughout the world as a parasite fighter as a prophylactic targeting SARS-CoV-2, the virus behind COVID-19.

Three Indian states, including Goa, Karnataka and Uttarakhand, have authorized ivermectin as a prophylaxis along with vitamin D during the pandemic. Now Maharashtra, home to about 126 million people and the city of Mumbai, filed an action with the Mumbai high court yesterday directing the central government to file an affidavit based on public interest litigation (PIL) that too calls for ivermectin and vitamin D as a prophylactic regimen in the COVID-19 protocol. 

Two justices, Amjad Sayed and Girish Kulkarni sought to elicit the central government’s stance on this request. According to the Times of India article, Dr. S M Tayde representing the health services of Mumbai had a response submitted opposing the PIL, declaring no new advisory is necessary given the state of Maharashtra already has issued a state-wide protocol incorporating ivermectin for a course of treatment for COVID-19 patients in combination with home isolation and or hospitalization. This protocol was enacted on April 8, 2021. 

Apparently, the matter will be dealt with in June. In the meantime, an unprecedented turnaround in the nation’s most populated state has been supported by an aggressive, population-wide scheme using ivermectin-based home medicine kits.

So, essentially, this was a legal move to persuade the national government to add to its national ivermectin protocol use as a prophylaxis as well as a treatment once an individual has been infected with the virus.

WHO Suppresses Key Information

TrialSite notes that since Uttar Pradesh, the nation’s most populated state, implemented an aggressive, population-wide ivermectin regimen, the COVID-19 case count absolutely plummeted. An amazing turnaround that’s been completely ignored by all the media. 

Of course, the correlation between the Uttar Pradesh embrace of an ivermectin-based population-wide regimen and the dramatic turnaround in COVID-19 cases cannot be statistically correlated without further study.

But a review of the Johns Hopkins University CSEE data depicts the state as home to a rapidly declining COVID-19 infection rate. 

The World Health Organization (WHO) touts the local action in Uttar Pradesh, including the “medicine kits” proactively given out but suppresses the fact that Ivermectin is used. How about local media? Are they suppressing this information too? 

According to the Hindustan Times, the state accounts for 74.55% of the new COVID-19 recoveries. And the press censorship of state health authority-sanctioned ivermectin use applies even to local Indian media. A number of factors are attributed to the striking turnaround from a local track and trace program as well as health department door-to-door screenings, which of course includes the ivermectin-based medicine kits. 

According to government data, about 1.6 million vaccine doses have been administered in the state, which again has over 210 million people.







Related: INDIA: Uttarakhand State Distributes Ivermectin to Combat COVID-19 Following Uttar Pradesh, Goa & Karnataka

Dr Pierre Kory Talks Ivermectin Success – Benefits Ricochet Around the World

The International Ivermectin for Covid Conference​: Medical ethics and ivermectin

Interview with Zimbabwe’s Dr. Jackie Stone: COVID-19 Infection & DEATH RATES PLUMMET Post MCAZ green light for Ivermectin Use

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Ivermectin Authorised in Indonesia as Pharma Issued License for Production to Battle COVID-19

For months, India’s national authorities have authorized ivermectin as a regimen to be included targeting COVID-19 yet this authorization was then removed due in part to both internal and external political pressure. Now the world’s fourth most populous nation’s regulatory authority has authorised ivermectin’s use in a major breakthrough for the drug’s role in the COVID-19 pandemic.

Read More »